1. Home
  2. OOMA vs ORGO Comparison

OOMA vs ORGO Comparison

Compare OOMA & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ooma Inc.

OOMA

Ooma Inc.

HOLD

Current Price

$17.75

Market Cap

408.2M

Sector

Technology

ML Signal

HOLD

Logo Organogenesis Holdings Inc.

ORGO

Organogenesis Holdings Inc.

HOLD

Current Price

$2.63

Market Cap

348.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
OOMA
ORGO
Founded
2003
1985
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
408.2M
348.6M
IPO Year
2015
2016

Fundamental Metrics

Financial Performance
Metric
OOMA
ORGO
Price
$17.75
$2.63
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
2
Target Price
$18.77
$8.50
AVG Volume (30 Days)
220.1K
1.8M
Earning Date
05-27-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
188.46
1600.00
EPS
0.23
0.15
Revenue
$114,490,000.00
$564,169,000.00
Revenue This Year
$20.35
N/A
Revenue Next Year
$4.17
$26.27
P/E Ratio
$71.00
$15.57
Revenue Growth
9.53
17.04
52 Week Low
$9.79
$2.21
52 Week High
$16.89
$7.08

Technical Indicators

Market Signals
Indicator
OOMA
ORGO
Relative Strength Index (RSI) 80.02 57.30
Support Level $10.95 $2.26
Resistance Level N/A $4.12
Average True Range (ATR) 0.56 0.14
MACD 0.14 0.03
Stochastic Oscillator 98.71 88.61

Price Performance

Historical Comparison
OOMA
ORGO

About OOMA Ooma Inc.

Ooma Inc is a communications services company. It is a smart software-as-a-service (SaaS) and unified communications platform that deliver voice and collaboration features including messaging, intelligent virtual attendants and video conferencing, and residential phone service provides PureVoice high-definition voice quality, advanced functionality and integration with mobile devices. Its services rely upon the following main elements: multi-tenant cloud service, on-premise devices, desktop and mobile applications, and calling platforms. It generates revenues from the sale of subscriptions and other services.

About ORGO Organogenesis Holdings Inc.

Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.

Share on Social Networks: